KLK3 and benign prostatic hyperplasia: Recently, Lang et al.55 which used MS analyses to quantify core fucosylated glycoforms of PSA, described that the percentage of core fucose glycoforms of PSA shows a decreasing trend in aggressive cancers, but it is not significant enough to improve the distinction between non-aggressive and aggressive PCa or between BPH and PCa.